The WasteWatcher
340B Drug Discount Program is a Nightmare
Like many other well-intended programs 340B has ended up both wasting money and failing to provide benefits for patients.
Kansas Bankrolls Buc-ee the Beaver
Kansas lawmakers gave tax-free public financing to a powerful private interest.
The Proposed Musk Efficiency Commission Could Save Trillions
Trump saying that trillions of dollars can be saved from a government efficiency commission headed by Musk isn't an exaggeration.
Price Controls Are Always a Bad Idea
Prices controls have always disrupted the marketplace and created shortages or excesses.
The Future of the Universal Service Fund
To save taxpayer dollars, Congress should look at revamping the USF program instead of trying to expanding its contribution base.
The Case for 340B Reform Is Made on Capitol Hill
At a Capitol Hill briefing on the urgent need for reforms to the 340B Drug Pricing Program, the case was made for prompt action to fix the program. The event took place at the Senate Visitors Center on September 23, 2024, and was hosted by the...
Protecting Intellectual Property in an AI World
Intellectual property rights should be protected when artificial intelligence is used in creative works.
USPTO-FDA Study Debunks Critics and Demonstrates the Importance of Protecting IP
USPTO-FDA study reinforces the need to protect pharmaceutical intellectual property rights for the future of new drug development.
The IRA Has Undermined Medicare Part D
The Inflation Reduction Act creates instability in the Medicare Part D Program.
Not-So-Happy Birthday to the Inflation Reduction Act
The Inflation Reduction Act will ultimately raise drug costs and reduce future cures.
Court Further Delays Net Neutrality Implementation
On August 1, 2024, the U.S. Court of Appeals for the Sixth Circuit extended the stay on the FCC's latest net neutrality order.
Fifth Circuit Determines the USF Fee Is a Tax
The Fifth Circuit Court rocked the telecommunications world when it released its ruling on funding the USF.